Pfizer reports Phase 3 TALAPRO-3 results showing improved outcomes in metastatic prostate cancer

Mabtech partners with Sai Life Sciences to expand access to EYRA multiplex immunology platform

Samsung Bioepis partners with Sandoz on up to five next-generation biosimilars

Avacta opens Phase 1 trial for AVA6103 cancer therapy in US

Imfinzi approved in EU for perioperative treatment of early gastric and gastroesophageal cancers

Aditxt acquires Ignite Proteomics to enhance cancer therapy selection

NASA awards Redwire USD4m to advance drug development in microgravity

Elicera Therapeutics receives Japanese patent allowance for ELC-401 CAR T-cell candidate

Curatis and Neupharma partner to develop corticorelin for peritumoral brain edema in Japan

Citius Oncology reports positive topline results from Phase 1 clinical trial of LYMPHIR combination

GenomOncology partners with WeTrials to support CNS cancer clinical trials

Agenus triggers USD20m milestone payment under Zydus manufacturing collaboration

AstraZeneca and Daiichi Sankyo's Enhertu receives US priority review for post-neoadjuvant HER2-positive early breast cancer

Zelluna partners with Etcembly to advance AI-driven TCR engineering for solid tumours

IDEAYA Biosciences enrols first patient in Phase 1 trial of PRMT5 inhibitor IDE892